Thermo Fisher Scientific (TMO) Change in Accured Expenses (2009 - 2019)

Thermo Fisher Scientific has reported Change in Accured Expenses for 11 years, with the latest figure at $38.0 million in Q4 2019.

• Change in Accured Expenses for Q4 2019 came in at $38.0 million, down 75.8% year-over-year; the trailing twelve-month figure through Dec 2019 was $210.0 million (up 600.0% YoY), and the FY2019 annual result was $210.0 million, up 600.0% from the prior year.
• Change in Accured Expenses advanced to $38.0 million in Q4 2019, from -$147.0 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $992.0 million in Q4 2017 and troughed at -$471.0 million in Q1 2018.
• A 5-year average of $80.0 million and a median of $115.2 million in 2015 frame the typical range for Change in Accured Expenses.
• The largest YoY upside for Change in Accured Expenses was 12019.44% in 2015 against a maximum downside of 247.98% in 2015.
• A 5-year view of Change in Accured Expenses shows it stood at $436.3 million in 2015, then fell by 16.89% to $362.6 million in 2016, then soared by 173.58% to $992.0 million in 2017, then slumped by 84.17% to $157.0 million in 2018, then plunged by 75.8% to $38.0 million in 2019.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $38.0 million in Q4 2019, -$147.0 million in Q3 2019, and $549.0 million in Q2 2019.